Bank of America Global Healthcare Conference 2026 May 12, 2026 6:00 PM EDTCompany ParticipantsRoland Sackers - CFO, MD & Member ...

Builds on approximately $300 million returned to shareholders in early 2024 as part of commitment to return at least $1 billion through end-2028 VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V.

Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board after deciding not to stand ...

The law firm of Kirby McInerney LLP is investigating potential claims against Qiagen N.V. ("Qiagen" or the "Company") (NYSE:QGEN). The investigation concerns whether the Company a ...

Have you assessed how the international operations of Qiagen (QGEN) performed in the quarter ended March 2026? For this diagnostic products maker, possessing an expansive global footprint, parsing the ...

Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing May 7, 2026 9:30 AM ...

Thank you, Dominica, and good morning, good afternoon, good evening, to all of you. Thanks again for your attention and interest in Qiagen N.V. A year ago, and I hope and I think that most of you ...

May 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Qiagen ...

As announced April 27, net sales for Q1 2026 rose 2% on a reported basis to $492 million, while sales at constant exchange rates (CER) were down 1%, compared with the outlook for at least 1% CER ...

Qiagen N.V. shares fell more than 10.5% after the company disclosed QuantiFERON faltered on "significantly lower immigration testing demand." Shareholders who lost money on Qiagen are encouraged to ...

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share. The diagnostic products maker posted revenue of $492.3 million in the period, which ...